Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 27
Filtrar
1.
J Virol ; 88(16): 9153-65, 2014 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-24899194

RESUMO

UNLABELLED: Human influenza cases caused by a novel avian H7N9 virus in China emphasize the zoonotic potential of that subtype. We compared the infectivity and pathogenicity of the novel H7N9 virus with those of a recent European avian H7N7 strain in chickens, pigeons, and ferrets. Neither virus induced signs of disease despite substantial replication in inoculated chickens and rapid transmission to contact chickens. Evidence of the replication of both viruses in pigeons, albeit at lower levels of RNA excretion, was also detected. No clear-cut differences between the two H7 isolates emerged regarding replication and antibody development in avian hosts. In ferrets, in contrast, greater replication of the avian H7N9 virus than of the H7N7 strain was observed with significant differences in viral presence, e.g., in nasal wash, lung, and cerebellum samples. Importantly, both viruses showed the potential to spread to the mammal brain. We conclude that efficient asymptomatic viral replication and shedding, as shown in chickens, facilitate the spread of H7 viruses that may harbor zoonotic potential. Biosafety measures are required for the handling of poultry infected with avian influenza viruses of the H7 subtype, independently of their pathogenicity for gallinaceous poultry. IMPORTANCE: This study is important to the field since it provides data about the behavior of the novel H7N9 avian influenza virus in chickens, pigeons, and ferrets in comparison with that of a recent low-pathogenicity H7N7 strain isolated from poultry. We clearly show that chickens, but not pigeons, are highly permissive hosts of both H7 viruses, allowing high-titer replication and virus shedding without any relevant clinical signs. In the ferret model, the potential of both viruses to infect mammals could be demonstrated, including infection of the brain. However, the replication efficiency of the H7N9 virus in ferrets was higher than that of the H7N7 strain. In conclusion, valuable data for the risk analysis of low-pathogenicity avian influenza viruses of the H7 subtype are provided that could also be used for the risk assessment of zoonotic potentials and necessary biosafety measures.


Assuntos
Galinhas/virologia , Columbidae/virologia , Furões/virologia , Vírus da Influenza A Subtipo H7N7/genética , Subtipo H7N9 do Vírus da Influenza A/genética , Virulência/genética , Adulto , Animais , Aves/virologia , China , Feminino , Humanos , Influenza Aviária/genética , Influenza Aviária/virologia , Influenza Humana/genética , Influenza Humana/virologia , Infecções por Orthomyxoviridae/genética , Infecções por Orthomyxoviridae/virologia , RNA Viral/genética , Replicação Viral/genética , Eliminação de Partículas Virais/genética
2.
J Virol ; 87(24): 13556-68, 2013 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-24109212

RESUMO

Influenza viruses are highly genetically variable and escape from immunogenic pressure by antigenic changes in their surface proteins, referred to as "antigenic drift" and "antigenic shift." To assess the potential genetic plasticity under strong selection pressure, highly pathogenic avian influenza virus (HPAIV) of subtype H5N1 was passaged 50 times in embryonated chicken eggs in the presence of a neutralizing, polyclonal chicken serum. The resulting mutant acquired major alterations in the neuraminidase (NA)-encoding segment. Extensive deletions and rearrangements were detected, in contrast to only 12 amino acid substitutions within all other segments. Interestingly, this new neuraminidase segment resulted from complex sequence shuffling and insertion of a short fragment originating from the PA segment. Characterization of that novel variant revealed a loss of the neuraminidase protein and enzymatic activity, but its replication efficiency remained comparable to that of the wild type. Using reverse genetics, a recombinant virus consisting of the wild-type backbone and the shortened NA segment could be generated; however, generation of this recombinant virus required the polybasic hemagglutinin cleavage site. Two independent repetitions starting with egg passage 30 in the presence of alternative chicken-derived immune sera selected mutants with similar but different large deletions within the NA segment without any neuraminidase activity, indicating a general mechanism. In chicken, these virus variants were avirulent, even though the HPAIV polybasic hemagglutinin cleavage site was still present. Overall, the variants reported here are the first HPAIV H5N1 strains without a functional neuraminidase shown to grow efficiently without any helper factor. These novel HPAIV variants may facilitate future studies shedding light on the role of neuraminidase in virus replication and pathogenicity.


Assuntos
Virus da Influenza A Subtipo H5N1/enzimologia , Virus da Influenza A Subtipo H5N1/fisiologia , Influenza Aviária/virologia , Neuraminidase/genética , Doenças das Aves Domésticas/virologia , Deleção de Sequência , Proteínas Virais/genética , Replicação Viral , Substituição de Aminoácidos , Animais , Galinhas , Virus da Influenza A Subtipo H5N1/genética , Mutagênese Insercional , Neuraminidase/química , Neuraminidase/deficiência , Inoculações Seriadas , Proteínas Virais/química , Proteínas Virais/metabolismo
3.
BMC Vet Res ; 10: 78, 2014 Apr 01.
Artigo em Inglês | MEDLINE | ID: mdl-24690234

RESUMO

BACKGROUND: By using animal sera as sentinels, natural TBEV foci could be identified and further analyses including investigations of ticks could be initiated. However, antibody response against TBEV-related flaviviruses might adversely affect the readout of such a monitoring. Therefore, the cross-reactivity of the applied TBEV serology test systems - enzyme linked immunosorbent assay (ELISA) and virus neutralization test (VNT) - as well as the longevity of TBEV antibody titres in sheep and goats were investigated in this study. RESULTS: Cross-reactivity of the TBEV antibody test systems with defined antibody-positive samples against selected members of the Flaviviridae family (e.g. Louping ill virus, West Nile virus) was observed for Louping-ill-positive sera only. In contrast, the commercial West Nile virus (WNV) competitive ELISA showed a high level of cross-reactivity with TBEV-specific positive sera.To assess the longevity of TBEV antibody titres, sera from two sheep and two goats, which had been immunized four times with a commercially available TBEV vaccine, were tested routinely over 28 months. In three of the four animals, TBEV-specific antibody titres could be detected over the whole test period.In addition, sera from the years 2010 and 2011 were collected in flocks in different villages of Baden-Württemberg and Thuringia to allow re-examination two to four years after the initial analysis. Interestingly, in most cases the results of the former investigations were confirmed, which may be caused by steadily existing natural TBEV foci. CONCLUSION: Cross-reactivity must be taken into consideration, particularly for TBEV serology in regions with a prevalence of Louping ill virus and for serological testing of WNV by cross-reactive ELISAs. Furthermore, over-interpretation of single TBEV-positive serological results should be avoided, especially in areas without a TBEV history.


Assuntos
Anticorpos Antivirais/imunologia , Vírus da Encefalite Transmitidos por Carrapatos/imunologia , Encefalite Transmitida por Carrapatos/veterinária , Animais , Reações Cruzadas/imunologia , Encefalite Transmitida por Carrapatos/imunologia , Ensaio de Imunoadsorção Enzimática/veterinária , Doenças das Cabras/imunologia , Doenças das Cabras/virologia , Cabras/imunologia , Cabras/virologia , Doenças dos Cavalos/imunologia , Doenças dos Cavalos/virologia , Cavalos/imunologia , Cavalos/virologia , Masculino , Testes de Neutralização/veterinária , Ovinos/imunologia , Ovinos/virologia , Doenças dos Ovinos/imunologia , Doenças dos Ovinos/virologia , Carrapatos/virologia , Fatores de Tempo
4.
J Virol ; 86(3): 1394-404, 2012 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-22090121

RESUMO

Influenza A viruses are one of the major threats in modern health care. Novel viruses arise due to antigenic drift and antigenic shift, leading to escape from the immune system and resulting in a serious problem for disease control. In order to investigate the escape process and to enable predictions of escape, we serially passaged influenza A H5N1 virus in vitro 100 times under immune pressure. The generated escape viruses were characterized phenotypically and in detail by full-genome deep sequencing. Mutations already found in natural isolates were detected, evidencing the in vivo relevance of the in vitro-induced amino acid substitutions. Additionally, several novel alterations were triggered. Altogether, the results imply that our in vitro system is suitable to study influenza A virus evolution and that it might even be possible to predict antigenic changes of influenza A viruses circulating in vaccinated populations.


Assuntos
Glicoproteínas de Hemaglutininação de Vírus da Influenza/química , Virus da Influenza A Subtipo H5N1/patogenicidade , Testes de Neutralização , Sequência de Aminoácidos , Animais , Anticorpos Antivirais/imunologia , Afinidade de Anticorpos , Sequência de Bases , Linhagem Celular , Galinhas , Primers do DNA , Imunofluorescência , Virus da Influenza A Subtipo H5N1/química , Virus da Influenza A Subtipo H5N1/imunologia , Dados de Sequência Molecular , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Homologia de Sequência de Aminoácidos
5.
Virol J ; 10: 284, 2013 Sep 12.
Artigo em Inglês | MEDLINE | ID: mdl-24028349

RESUMO

BACKGROUND: High resolution melting analysis (HRM) is a rapid and cost-effective technique for the characterisation of PCR amplicons. Because the reverse genetics of segmented influenza A viruses allows the generation of numerous influenza A virus reassortants within a short time, methods for the rapid selection of the correct recombinants are very useful. METHODS: PCR primer pairs covering the single nucleotide polymorphism (SNP) positions of two different influenza A H5N1 strains were designed. Reassortants of the two different H5N1 isolates were used as a model to prove the suitability of HRM for the selection of the correct recombinants. Furthermore, two different cycler instruments were compared. RESULTS: Both cycler instruments generated comparable average melting peaks, which allowed the easy identification and selection of the correct cloned segments or reassorted viruses. CONCLUSIONS: HRM is a highly suitable method for the rapid and precise characterisation of cloned influenza A genomes.


Assuntos
Virus da Influenza A Subtipo H5N1/classificação , Virus da Influenza A Subtipo H5N1/genética , Biologia Molecular/métodos , RNA Viral/genética , Temperatura de Transição , Virologia/métodos , Humanos , Vírus Reordenados/classificação , Vírus Reordenados/genética , Genética Reversa/métodos
6.
J Virol ; 85(20): 10691-8, 2011 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-21849466

RESUMO

H5N1 highly pathogenic avian influenza viruses (HPAIV) of clade 2.2 spread from Southeast Asia to Europe. Intriguingly, in contrast to all common avian strains specifying glutamic acid at position 627 of the PB2 protein (PB2-627E), they carry a lysine at this position (PB2-627K), which is normally found only in human strains. To analyze the impact of this mutation on the host range of HPAIV H5N1, we altered PB2-627K to PB2-627E in the European isolate A/Swan/Germany/R65/2006 (R65). In contrast to the parental R65, multicycle growth and polymerase activity of the resulting mutant R65-PB2(K627E) were considerably impaired in mammalian but not in avian cells. Correspondingly, the 50% lethal dose (LD50) in mice was increased by three orders of magnitude, whereas virulence in chicken remained unchanged, resulting in 100% lethality, as was found for the parental R65. Strikingly, R65-PB2(K627E) reverted to PB2-627K after only one passage in mice but did not revert in chickens. To investigate whether additional R65 genes influence reversion, we passaged R65-PB2(K627E) reassortants containing genes from A/Hong Kong/156/97 (H5N1) (carrying PB2-627E), in avian and mammalian cells. Reversion to PB2-627K in mammalian cells required the presence of the R65 nucleoprotein (NP). This finding corresponds to results of others that during replication of avian strains in mammalian cells, PB2-627K restores an impaired PB2-NP association. Since this mutation is apparently not detrimental for virus prevalence in birds, it has not been eliminated. However, the prompt reversion to PB2-627K in MDCK cells and mice suggests that the clade 2.2 H5N1 HPAIV may have had a history of intermediate mammalian hosts.


Assuntos
Substituição de Aminoácidos/genética , Especificidade de Hospedeiro , Virus da Influenza A Subtipo H5N1/crescimento & desenvolvimento , Virus da Influenza A Subtipo H5N1/patogenicidade , Mutação de Sentido Incorreto , RNA Polimerase Dependente de RNA/genética , Proteínas Virais/genética , Animais , Aves , Linhagem Celular , Galinhas , Modelos Animais de Doenças , Feminino , Humanos , Virus da Influenza A Subtipo H5N1/genética , Virus da Influenza A Subtipo H5N1/isolamento & purificação , Dose Letal Mediana , Camundongos , Camundongos Endogâmicos BALB C , Infecções por Orthomyxoviridae/mortalidade , Infecções por Orthomyxoviridae/virologia , Doenças das Aves Domésticas/mortalidade , Doenças das Aves Domésticas/virologia , Doenças dos Roedores/mortalidade , Doenças dos Roedores/virologia , Análise de Sobrevida
7.
J Virol ; 84(22): 12002-10, 2010 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-20810729

RESUMO

Highly pathogenic avian influenza (HPAI) is a striking disease in susceptible poultry, which leads to severe economic losses. Inactivated vaccines are the most widely used vaccines in avian influenza virus (AIV) vaccination programs. However, these vaccines interfere with the serological detection of wild-type AIV infections in immunized populations. The use of vaccines that allow differentiation between infected and vaccinated animals (DIVA strategy) would stop current stamping-out policies. Therefore, novel vaccination strategies are needed to allow improved protection of animals and humans against HPAI virus (HPAIV) infection. The presented study analyzed for the first time the immunogenic capacity of plant-expressed full-length hemagglutinin (rHA0) of HPAIV H5N1 in several vaccine formulations within the highly relevant host species chicken. We were able to express plant-expressed rHA0 at high levels and could show that, when administered with potent adjuvants, it is highly immunogenic and can fully protect chicken against lethal challenge infection. Real-time reverse transcription (RT)-PCR and serological tests demonstrated only marginally increased virus replication in animals vaccinated with plant-derived rHA0 compared to animals immunized with an inactivated reference vaccine. In addition, the use of plant-expressed rHA0 also allowed an easy serological differentiation of vaccinated from AIV-infected animals based on antibodies against the influenza virus NP protein.


Assuntos
Expressão Gênica , Glicoproteínas de Hemaglutininação de Vírus da Influenza/genética , Glicoproteínas de Hemaglutininação de Vírus da Influenza/imunologia , Virus da Influenza A Subtipo H5N1/imunologia , Vacinas contra Influenza/imunologia , Influenza Aviária/prevenção & controle , Nicotiana/genética , Animais , Galinhas , Glicoproteínas de Hemaglutininação de Vírus da Influenza/administração & dosagem , Imunização , Virus da Influenza A Subtipo H5N1/genética , Virus da Influenza A Subtipo H5N1/patogenicidade , Virus da Influenza A Subtipo H5N1/fisiologia , Vacinas contra Influenza/administração & dosagem , Vacinas contra Influenza/genética , Influenza Aviária/imunologia , Influenza Aviária/virologia , Proteínas Recombinantes/administração & dosagem , Proteínas Recombinantes/genética , Proteínas Recombinantes/imunologia , Nicotiana/metabolismo
8.
J Virol ; 84(20): 10708-18, 2010 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-20686040

RESUMO

We assessed the prediction that access of the viral NS1 protein to cellular PDZ domain protein networks enhances the virulence of highly pathogenic avian influenza A viruses. The NS1 proteins of most avian influenza viruses bear the C-terminal ligand sequence Glu-Ser-Glu-Val (ESEV) for PDZ domains present in multiple host proteins, whereas no such motif is found in the NS1 homologues of seasonal human virus strains. Previous analysis showed that a C-terminal ESEV motif increases viral virulence when introduced into the NS1 protein of mouse-adapted H1N1 influenza virus. To examine the role of the PDZ domain ligand motif in avian influenza virus virulence, we generated three recombinants, derived from the prototypic H5N1 influenza A/Vietnam/1203/04 virus, expressing NS1 proteins that either have the C-terminal ESEV motif or the human influenza virus RSKV consensus or bear a natural truncation of this motif, respectively. Cell biological analyses showed strong control of NS1 nuclear migration in infected mammalian and avian cells, with only minor differences between the three variants. The ESEV sequence attenuated viral replication on cultured human, murine, and duck cells but not on chicken fibroblasts. However, all three viruses caused highly lethal infections in mice and chickens, with little difference in viral titers in organs, mean lethal dose, or intravenous pathogenicity index. These findings demonstrate that a PDZ domain ligand sequence in NS1 contributes little to the virulence of H5N1 viruses in these hosts, and they indicate that this motif modulates viral replication in a strain- and host-dependent manner.


Assuntos
Virus da Influenza A Subtipo H5N1/genética , Virus da Influenza A Subtipo H5N1/patogenicidade , Proteínas não Estruturais Virais/genética , Proteínas não Estruturais Virais/fisiologia , Motivos de Aminoácidos , Animais , Linhagem Celular , Embrião de Galinha , Galinhas , Patos , Feminino , Variação Genética , Interações Hospedeiro-Patógeno/genética , Interações Hospedeiro-Patógeno/imunologia , Interações Hospedeiro-Patógeno/fisiologia , Humanos , Virus da Influenza A Subtipo H5N1/fisiologia , Influenza Aviária/etiologia , Influenza Aviária/virologia , Interferon beta/biossíntese , Interferon beta/genética , Camundongos , Camundongos Endogâmicos BALB C , Infecções por Orthomyxoviridae/etiologia , Infecções por Orthomyxoviridae/patologia , Infecções por Orthomyxoviridae/virologia , Proteínas Recombinantes/química , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Especificidade da Espécie , Proteínas não Estruturais Virais/química , Virulência/genética , Virulência/fisiologia
9.
Emerg Infect Dis ; 16(4): 703-5, 2010 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-20350393

RESUMO

To determine susceptibility of chickens, turkeys, and mice to pandemic (H1N1) 2009 virus, we conducted contact exposure and inoculation experiments. We demonstrated that chickens were refractory to infection. However, oculo-oronasally inoculated turkeys and intranasally inoculated mice seroconverted without clinical signs of infection.


Assuntos
Galinhas/virologia , Vírus da Influenza A Subtipo H1N1/patogenicidade , Influenza Aviária/virologia , Infecções por Orthomyxoviridae/veterinária , Perus/virologia , Animais , Suscetibilidade a Doenças/veterinária , Influenza Aviária/imunologia , Camundongos/virologia , Infecções por Orthomyxoviridae/virologia , Doenças dos Roedores/virologia
10.
Emerg Infect Dis ; 14(7): 1132-4, 2008 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-18598640

RESUMO

Four calves were experimentally inoculated with highly pathogenic avian influenza virus A/cat/Germany/R606/2006 (H5N1) isolated from a cat in 2006. All calves remained healthy, but several animals shed low amounts of virus, detected by inoculation of nasal swab fluid into embryonated chicken eggs and onto MDCK cells. All calves seroconverted.


Assuntos
Portador Sadio/virologia , Virus da Influenza A Subtipo H5N1/patogenicidade , Infecções por Orthomyxoviridae , Animais , Anticorpos Antivirais/sangue , Portador Sadio/sangue , Bovinos , Modelos Animais de Doenças , Virus da Influenza A Subtipo H5N1/imunologia , Sistema Respiratório/virologia , Eliminação de Partículas Virais
11.
Emerg Infect Dis ; 14(8): 1267-70, 2008 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-18680652

RESUMO

Adult, healthy mute swans were experimentally infected with highly pathogenic avian influenza virus A/Cygnus cygnus/Germany/R65/2006 subtype H5N1. Immunologically naive birds died, whereas animals with preexisting, naturally acquired avian influenza virus-specific antibodies became infected asymptomatically and shed virus. Adult mute swans are highly susceptible, excrete virus, and can be clinically protected by preexposure immunity.


Assuntos
Anseriformes/virologia , Virus da Influenza A Subtipo H5N1/fisiologia , Influenza Aviária/virologia , Animais , Anticorpos Antivirais/imunologia , Encéfalo/virologia , Olho/virologia , Feminino , Influenza Aviária/imunologia , Influenza Aviária/mortalidade , Fígado/virologia , Masculino , RNA Viral/isolamento & purificação , Pele/virologia , Fatores de Tempo , Carga Viral , Replicação Viral , Eliminação de Partículas Virais
12.
J R Soc Interface ; 13(114): 20150976, 2016 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-26763336

RESUMO

Highly pathogenic avian influenza (HPAI) H5N1 epidemics in poultry cause huge economic losses as well as sporadic human morbidity and mortality. Vaccination in poultry has often been reported as being ineffective in preventing transmission and as a potential driving force in the selection of immune escape mutants. We conducted transmission experiments to evaluate the transmission dynamics of HPAI H5N1 strains in chickens vaccinated with high and low doses of immune escape mutants we have previously selected, and analysed the data using mathematical models. Remarkably, we demonstrate that the effect of antigenic distances between the vaccine and challenge strains used in this study is too small to influence the transmission dynamics of the strains used. This is because the effect of a sufficient vaccine dose on antibody levels against the challenge viruses is large enough to compensate for any decrease in antibody titres due to antigenic differences between vaccine and challenge strains. Our results show that at least under experimental conditions, vaccination will remain effective even after antigenic changes as may be caused by the initial selection in vaccinated birds.


Assuntos
Antígenos Virais/imunologia , Galinhas , Virus da Influenza A Subtipo H5N1/imunologia , Influenza Aviária , Doenças das Aves Domésticas , Vacinação , Animais , Galinhas/imunologia , Galinhas/virologia , Humanos , Virus da Influenza A Subtipo H5N1/patogenicidade , Influenza Aviária/imunologia , Influenza Aviária/prevenção & controle , Influenza Aviária/transmissão , Doenças das Aves Domésticas/imunologia , Doenças das Aves Domésticas/prevenção & controle , Doenças das Aves Domésticas/transmissão
13.
Vaccine ; 32(22): 2631-6, 2014 May 07.
Artigo em Inglês | MEDLINE | ID: mdl-24674664

RESUMO

Highly pathogenic avian influenza viruses of subtype H5N1 sporadically cause severe disease in humans and involve the risk of inducing a pandemic by gaining the ability for human-to-human transmission. In naïve poultry, primarily gallinaceous birds, the virus induces fatal disease and the used inactivated vaccines occasionally are unable to provide efficient and early onset of protection. Therefore, optimized vaccines must be developed and evaluated in model systems. In our study, we tested a novel H5 neuraminidase-deleted influenza A virus variant to analyze the induction of a very early onset of immunity. Ferrets, mice and chickens were each immunized with a single vaccine dose seven, three and one day before lethal challenge infection, respectively. Sound protection was conferred in 100% of animals immunized seven days prior to challenge infection. In these animals, no clinical signs were observed, and no challenge virus RNA was detected by real-time RT-PCR analyses of swabs, nasal washings, and organ samples. Moreover, the attenuated modified-live virus variant protected all chickens, mice, and ferrets as early as three days after vaccination against severe clinical signs. Chickens and ferrets developed hemagglutinin-specific antibodies after seven days, but no neuraminidase-specific antibodies, making this kind of neuraminidase-negative strain suitable for the DIVA ("differentiating vaccinated from infected animals") strategy.


Assuntos
Virus da Influenza A Subtipo H5N1 , Vacinas contra Influenza/administração & dosagem , Influenza Aviária/prevenção & controle , Infecções por Orthomyxoviridae/prevenção & controle , Animais , Anticorpos Antivirais/sangue , Galinhas , Feminino , Furões , Testes de Inibição da Hemaglutinação , Glicoproteínas de Hemaglutininação de Vírus da Influenza/imunologia , Virus da Influenza A Subtipo H5N1/genética , Camundongos , Camundongos Endogâmicos BALB C , Neuraminidase/genética , RNA Viral/isolamento & purificação , Deleção de Sequência , Carga Viral
14.
Vector Borne Zoonotic Dis ; 14(4): 303-5, 2014 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-24689730

RESUMO

Cowpox virus (CPXV) was isolated from a fatal outbreak among cotton-top tamarins. Samples from healthy common marmosets in contact were also CPXV genome positive. The CPXV isolated from the cotton-top tamarins exhibited a unique hemagglutinin sequence. Pathogenicity investigations using a Wistar rat model characterized the isolate as low pathogenic.


Assuntos
Vírus da Varíola Bovina/isolamento & purificação , Varíola Bovina/veterinária , Surtos de Doenças/veterinária , Doenças dos Macacos/epidemiologia , Saguinus/virologia , Animais , Varíola Bovina/epidemiologia , Varíola Bovina/virologia , Vírus da Varíola Bovina/genética , Vírus da Varíola Bovina/patogenicidade , Modelos Animais de Doenças , Feminino , Alemanha/epidemiologia , Hemaglutininas Virais/genética , Masculino , Doenças dos Macacos/virologia , Filogenia , Ratos , Ratos Wistar , Análise de Sequência de DNA/veterinária
15.
PLoS One ; 9(2): e84628, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-24586231

RESUMO

Evolution of Avian Influenza (AI) viruses--especially of the Highly Pathogenic Avian Influenza (HPAI) H5N1 subtype--is a major issue for the poultry industry. HPAI H5N1 epidemics are associated with huge economic losses and are sometimes connected to human morbidity and mortality. Vaccination (either as a preventive measure or as a means to control outbreaks) is an approach that splits the scientific community, due to the risk of it being a potential driving force in HPAI evolution through the selection of mutants able to escape vaccination-induced immunity. It is therefore essential to study how mutations are selected due to immune pressure. To this effect, we performed an in vitro selection of mutants from HPAI A/turkey/Turkey/1/05 (H5N1), using immune pressure from homologous polyclonal sera. After 42 rounds of selection, we identified 5 amino acid substitutions in the Haemagglutinin (HA) protein, most of which were located in areas of antigenic importance and suspected to be prone to selection pressure. We report that most of the mutations took place early in the selection process. Finally, our antigenic cartography studies showed that the antigenic distance between the selected isolates and their parent strain increased with passage number.


Assuntos
Aminoácidos/genética , Glicoproteínas de Hemaglutininação de Vírus da Influenza/genética , Soros Imunes/imunologia , Virus da Influenza A Subtipo H5N1/genética , Virus da Influenza A Subtipo H5N1/imunologia , Influenza Aviária/imunologia , Mutação/genética , Sequência de Aminoácidos , Substituição de Aminoácidos/genética , Substituição de Aminoácidos/imunologia , Aminoácidos/imunologia , Animais , Aves/imunologia , Aves/virologia , Surtos de Doenças , Glicoproteínas de Hemaglutininação de Vírus da Influenza/imunologia , Dados de Sequência Molecular , Mutação/imunologia , Vacinação/métodos
16.
J Virol Methods ; 174(1-2): 77-84, 2011 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-21458493

RESUMO

Two important components of control programs for Bovine herpesvirus type 1 (BoHV-1), a major pathogen of cattle, are the detection of outbreaks and vaccination with glycoprotein E (gE)-deleted marker vaccines. In addition to serology, rapid and accurate investigation of BoHV-1 and genetic differentiation of vaccine and wild-type strains are also important methods. Therefore, a triplex quantitative real-time polymerase chain reaction (qPCR) for testing BoHV-1 was developed. Apart from a BoHV-1 specific glycoprotein D (gD) assay, a gE-specific system for differentiation between wild-type BoHV-1 and gE-deleted vaccine strains was established. Finally, an internal control, based on the beta-actin gene was introduced successfully completing the multiplex system. The triplex BoHV-1-qPCR has an analytical sensitivity of less than 10 genome copies per reaction, and the diagnostic sensitivity was equal to or even greater than that of the 'gold standard' method of virus isolation in cell culture. A series of reference strains, including gE-deleted BoHV-1 and field isolates were detected reliably. For validation of the specificity of the test, nasal swabs, semen and different organ material from cattle, negative for BoHV-1, and genetically related herpesvirus strains were examined. The new multiplex BoHV-1-specific qPCR system allows highly sensitive and rapid genetic detection and differentiation of BoHV-1 and will be a valuable method for the control of BoHV-1 infection.


Assuntos
Doenças dos Bovinos/virologia , Técnicas de Laboratório Clínico/métodos , Infecções por Herpesviridae/veterinária , Reação em Cadeia da Polimerase/métodos , Proteínas Virais/genética , Vacinas Virais/genética , Virologia/métodos , Actinas/genética , Animais , Bovinos , Doenças dos Bovinos/prevenção & controle , Técnicas de Laboratório Clínico/normas , Infecções por Herpesviridae/prevenção & controle , Infecções por Herpesviridae/virologia , Herpesvirus Bovino 1/genética , Herpesvirus Bovino 1/isolamento & purificação , Reação em Cadeia da Polimerase/normas , Padrões de Referência , Sensibilidade e Especificidade , Vacinas Marcadoras/genética , Virologia/normas
17.
Vet Microbiol ; 153(3-4): 382-6, 2011 Dec 15.
Artigo em Inglês | MEDLINE | ID: mdl-21724342

RESUMO

A pet rat derived cowpox virus strain, which was also the source of human infections, was used to infect young Wistar and fancy rats. After an incubation period of 6 days the animals developed a severe, often fatal disease with high amounts of virus detected in oropharyngeal secretions.


Assuntos
Vírus da Varíola Bovina/fisiologia , Varíola Bovina/veterinária , Animais , Varíola Bovina/diagnóstico , Varíola Bovina/mortalidade , Varíola Bovina/patologia , DNA Viral/isolamento & purificação , Reservatórios de Doenças , Animais de Estimação/virologia , Reação em Cadeia da Polimerase , Ratos , Ratos Wistar , Eliminação de Partículas Virais
18.
Vet Microbiol ; 154(1-2): 113-23, 2011 Dec 29.
Artigo em Inglês | MEDLINE | ID: mdl-21803510

RESUMO

In 2009, a novel swine-origin H1N1 influenza A virus (S-OIV), antigenically and genetically divergent from seasonal H1N1, caused a flu pandemic in humans. Development of an effective vaccine to limit transmission of S-OIV in animal reservoir hosts and from reservoir hosts to humans and animals is necessary. In the present study, we constructed and evaluated a vectored vaccine expressing the H1 hemagglutinin of a recent S-OIV isolate using equine herpesvirus 1 (EHV-1) as the delivery vehicle. Expression of the recombinant protein was demonstrated by immunofluorescence and western blotting and the in vitro growth properties of the modified live vector were found to be comparable to those of the parental virus. The EHV-1-H1 vaccine induced an influenza virus-specific antibody response when inoculated into mice by both the intranasal and subcutaneous routes. Upon challenge infection, protection of vaccinated mice could be demonstrated by reduction of clinical signs and faster virus clearance. Our study shows that an EHV-1-based influenza H1N1 vaccine may be a promising alternative for protection against S-OIV infection.


Assuntos
Glicoproteínas de Hemaglutininação de Vírus da Influenza/imunologia , Herpesvirus Equídeo 1/imunologia , Vírus da Influenza A Subtipo H1N1/imunologia , Vacinas contra Influenza/imunologia , Infecções por Orthomyxoviridae/prevenção & controle , Animais , Anticorpos Neutralizantes/sangue , Anticorpos Antivirais/sangue , Feminino , Vetores Genéticos , Glicoproteínas de Hemaglutininação de Vírus da Influenza/genética , Herpesvirus Equídeo 1/genética , Imunidade Humoral , Vacinas contra Influenza/administração & dosagem , Vacinas contra Influenza/genética , Camundongos , Camundongos Endogâmicos BALB C , Infecções por Orthomyxoviridae/imunologia , Proteínas Recombinantes/genética , Proteínas Recombinantes/imunologia
19.
Vet Microbiol ; 140(3-4): 237-45, 2010 Jan 27.
Artigo em Inglês | MEDLINE | ID: mdl-19782482

RESUMO

Zoonotic agents challenging the world every year afresh are influenza A viruses. In the past, human pandemics caused by influenza A viruses had been occurring periodically. Wild aquatic birds are carriers of the full variety of influenza virus A subtypes, and thus, most probably constitute the natural reservoir of all influenza A viruses. Whereas avian influenza viruses in their natural avian reservoir are generally of low pathogenicity (LPAIV), some have gained virulence by mutation after transmission and adaptation to susceptible gallinaceous poultry. Those so-called highly pathogenic avian influenza viruses (HPAIV) then cause mass die-offs in susceptible birds and lead to tremendous economical losses when poultry is affected. Besides a number of avian influenza virus subtypes that have sporadically infected mammals, the HPAIV H5N1 Asia shows strong zoonotic characteristics and it was transmitted from birds to different mammalian species including humans. Theoretically, pandemic viruses might derive directly from avian influenza viruses or arise after genetic reassortment between viruses of avian and mammalian origin. So far, HPAIV H5N1 already meets two conditions for a pandemic virus: as a new subtype it has been hitherto unseen in the human population and it has infected at least 438 people, and caused severe illness and high lethality in 262 humans to date (August 2009). The acquisition of efficient human-to-human transmission would complete the emergence of a new pandemic virus. Therefore, fighting H5N1 at its source is the prerequisite to reduce pandemic risks posed by this virus. Other influenza viruses regarded as pandemic candidates derive from subtypes H2, H7, and H9 all of which have infected humans in the past. Here, we will give a comprehensive overview on avian influenza viruses in concern to their zoonotic potential.


Assuntos
Virus da Influenza A Subtipo H5N1/isolamento & purificação , Influenza Aviária/epidemiologia , Influenza Aviária/virologia , Influenza Humana/epidemiologia , Influenza Humana/virologia , Zoonoses/virologia , Animais , Aves , Surtos de Doenças/prevenção & controle , Humanos , Virus da Influenza A Subtipo H5N1/patogenicidade , Influenza Aviária/transmissão , Influenza Humana/transmissão , Mamíferos , Aves Domésticas/virologia , Zoonoses/transmissão
20.
Vaccine ; 28(36): 5871-7, 2010 Aug 16.
Artigo em Inglês | MEDLINE | ID: mdl-20600486

RESUMO

Western European control programs against bovine herpesvirus type 1 (BoHV-1) infections utilize attenuated BoHV-1 marker vaccines with a deletion of the glycoprotein E (gE) encoding gene. However, a recent study demonstrated the potential risk of virulence recovery of gE-deleted BoHV-1 marker vaccine strains due to recombination (Muylkens et al. [15]). Based on an infectious bacterial artificial chromosome clone, a gE- and thymidine kinase (TK)-gene-deleted BoHV-1 mutant (BoHV-1DeltagEDeltaTK) was constructed. The recombinant virus was subsequently tested as a novel modified live marker vaccine candidate in an immunization-challenge trial using BoHV-1 seronegative calves. Additionally, a non-virucidal co-polymer was tested together with the recombinant virus acting as a vaccine-adjuvant. Animals were vaccinated twice through intramuscular injection and challenged intranasally 3 weeks later with a virulent BoHV-1 field strain. Duration and titres of challenge virus shedding were significantly reduced in all vaccinees. Importantly, reduction of challenge virus shedding and serological antibody levels in response to vaccination with vaccine preparations containing the co-polymer-adjuvant were markedly improved when compared to vaccine formulations without an adjuvant. Taken together, our study describes a novel double deletion mutant as a safe and efficacious BoHV-1-prototype marker vaccine strain with enhanced protective capacity especially when administered together with a co-polymer adjuvant.


Assuntos
Doenças dos Bovinos/prevenção & controle , Infecções por Herpesviridae/veterinária , Vacinas contra Herpesvirus/imunologia , Proteínas Virais/imunologia , Adjuvantes Imunológicos/administração & dosagem , Animais , Anticorpos Antivirais/sangue , Bovinos , Doenças dos Bovinos/imunologia , Feminino , Infecções por Herpesviridae/imunologia , Infecções por Herpesviridae/prevenção & controle , Herpesvirus Bovino 1/genética , Herpesvirus Bovino 1/patogenicidade , Deleção de Sequência , Eliminação de Partículas Virais
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa